Total Payments
$2,787
2024 Payments
$64.99
Companies
21
Transactions
150
Medicare Patients
4,042
Medicare Billing
$255,771
Payment Breakdown by Category
Food & Beverage$2,648 (95.0%)
Education$119.98 (4.3%)
Other$18.84 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,648 | 147 | 95.0% |
| Education | $119.98 | 2 | 4.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $18.84 | 1 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $943.27 | 66 | $0 (2023) |
| Janssen Biotech, Inc. | $286.92 | 10 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $279.52 | 7 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $233.89 | 23 | $0 (2023) |
| GENZYME CORPORATION | $208.66 | 5 | $0 (2023) |
| Sun Pharmaceutical Industries Inc. | $189.77 | 5 | $0 (2023) |
| Amgen Inc. | $97.53 | 4 | $0 (2023) |
| Almirall LLC | $74.15 | 5 | $0 (2023) |
| UCB, Inc. | $68.97 | 3 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $67.45 | 3 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $64.99 | 1 | Janssen Biotech, Inc. ($64.99) |
| 2023 | $1,053 | 64 | ABBVIE INC. ($330.94) |
| 2022 | $953.73 | 48 | ABBVIE INC. ($390.68) |
| 2021 | $715.04 | 37 | AbbVie Inc. ($221.65) |
All Payment Transactions
150 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/02/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $64.99 | General |
| Category: Immunology | ||||||
| 12/12/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $21.06 | General |
| Category: Dermatology | ||||||
| 12/07/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: IMMUNOLOGY | ||||||
| 12/07/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $3.33 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $4.35 | General |
| Category: Dermatology | ||||||
| 12/05/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $2.53 | General |
| Category: Dermatology | ||||||
| 11/29/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $7.84 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $2.82 | General |
| Category: Dermatology | ||||||
| 11/21/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $0.20 | General |
| Category: Dermatology | ||||||
| 11/17/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2023 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: Immunology | ||||||
| 11/08/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | CYLTEZO (Drug) | Food and Beverage | In-kind items and services | $19.28 | General |
| Category: CNS | ||||||
| 10/24/2023 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $29.70 | General |
| Category: Dermatology | ||||||
| 10/17/2023 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $17.61 | General |
| Category: Immunology | ||||||
| 10/10/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: IMMUNOLOGY | ||||||
| 10/10/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $3.66 | General |
| Category: Dermatology | ||||||
| 09/26/2023 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $22.15 | General |
| 09/19/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $12.19 | General |
| Category: IMMUNOLOGY | ||||||
| 09/07/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $6.08 | General |
| Category: IMMUNOLOGY | ||||||
| 09/06/2023 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $23.16 | General |
| Category: Immunology | ||||||
| 09/05/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $17.20 | General |
| Category: Immunology | ||||||
| 08/30/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $20.21 | General |
| Category: IMMUNOLOGY | ||||||
| 08/30/2023 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: Immunology | ||||||
| 08/24/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $2.82 | General |
| Category: Dermatology | ||||||
| 08/22/2023 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $26.75 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 1,012 | 2,078 | $307,081 | $57,022 |
| 2022 | 11 | 1,064 | 2,157 | $364,142 | $70,890 |
| 2021 | 12 | 1,040 | 2,204 | $296,230 | $65,906 |
| 2020 | 11 | 926 | 2,309 | $294,929 | $61,953 |
Total Patients
4,042
Total Services
8,748
Medicare Billing
$255,771
Procedure Codes
45
All Medicare Procedures & Services
45 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 167 | 238 | $65,212 | $15,054 | 23.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 258 | 352 | $67,584 | $15,005 | 22.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 183 | 230 | $47,150 | $6,899 | 14.6% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 53 | 67 | $34,304 | $5,755 | 16.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 150 | 977 | $26,379 | $3,572 | 13.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 58 | 60 | $19,320 | $3,443 | 17.8% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 75 | 78 | $27,378 | $3,434 | 12.5% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 15 | 15 | $6,015 | $1,020 | 17.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 12 | 12 | $4,272 | $974.03 | 22.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 20 | 20 | $4,740 | $955.88 | 20.2% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 21 | 29 | $4,727 | $911.48 | 19.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 171 | 270 | $73,980 | $18,580 | 25.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 243 | 354 | $67,968 | $15,243 | 22.4% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 68 | 101 | $51,712 | $8,911 | 17.2% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 102 | 128 | $44,928 | $8,272 | 18.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 186 | 246 | $50,430 | $7,300 | 14.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 71 | 81 | $26,082 | $4,216 | 16.2% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 144 | 882 | $23,814 | $3,255 | 13.7% |
| 11104 | Punch biopsy, first skin growth | Office | 2022 | 20 | 22 | $8,822 | $1,736 | 19.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 27 | 27 | $6,399 | $1,236 | 19.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 13 | 13 | $4,628 | $1,149 | 24.8% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 19 | 33 | $5,379 | $990.96 | 18.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 276 | 409 | $64,213 | $18,994 | 29.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 146 | 210 | $48,720 | $13,654 | 28.0% |
| 17004 | Destruction of 15 or more premalignant skin growths | Office | 2021 | 70 | 109 | $49,050 | $9,168 | 18.7% |
About Jaimee Kamp, NP
Jaimee Kamp, NP is a Registered Nurse healthcare provider based in South Bend, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/11/2015. The National Provider Identifier (NPI) number assigned to this provider is 1346631496.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jaimee Kamp, NP has received a total of $2,787 in payments from pharmaceutical and medical device companies, with $64.99 received in 2024. These payments were reported across 150 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($2,648).
As a Medicare-enrolled provider, Kamp has provided services to 4,042 Medicare beneficiaries, totaling 8,748 services with total Medicare billing of $255,771. Data is available for 4 years (2020–2023), covering 45 distinct procedure/service records.
Ad
Practice Information
- Specialty Registered Nurse
- Other Specialties Nurse Practitioner, Family
- Location South Bend, IN
- Active Since 02/11/2015
- Last Updated 05/01/2023
- Taxonomy Code 163W00000X
- Entity Type Individual
- NPI Number 1346631496
Products in Payments
- DUPIXENT (Biological) $470.22
- RINVOQ (Biological) $436.03
- SKYRIZI (Biological) $397.44
- TREMFYA (Drug) $191.57
- ILUMYA (Biological) $147.46
- COSENTYX (Drug) $106.58
- Otezla (Drug) $97.53
- REMICADE (Biological) $95.35
- COSENTYX (Biological) $84.72
- HUMIRA (Biological) $80.57
- Cimzia (Drug) $68.97
- Sotyktu (Drug) $67.45
- TALTZ (Drug) $65.30
- Seysara (Drug) $61.66
- OPZELURA (Drug) $58.07
- ADBRY (Biological) $46.00
- Ilumya (Biological) $33.34
- LIBTAYO (Biological) $30.39
- Xeomin (Biological) $23.08
- CYLTEZO (Drug) $19.28
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Registered Nurse Doctors in South Bend
Tyne Simpson, Fnp, FNP
Registered Nurse — Payments: $2,543
Registered Nurse $2,543
Ruth Neal, Aprn, APRN
Registered Nurse — Payments: $2,414
Registered Nurse $2,414
Tamara Fuller, Fnp-Bc, FNP-BC
Registered Nurse — Payments: $2,123
Registered Nurse $2,123
Diane Sharkey, Np, NP
Registered Nurse — Payments: $1,126
Registered Nurse $1,126
Jaclyn Fusco
Registered Nurse — Payments: $747.26
Registered Nurse $747.26
Tiffany Rice, Fnp-C, FNP-C
Registered Nurse — Payments: $594.46
Registered Nurse $594.46